While Novo Nordisk says CagriSema will help users lose up to 25% of weight, duration will be clear when final results of its ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion sales in 2023, it shows no signs ...

GLP-1 agonists – of which Novo Nordisk’s Ozempic and Wegovy (semaglutide) and Eli Lilly’s Mounjaro (tirzepatide) are the most ...

If you said diabetes, you're right -- a new study finds diabetes costs $101 billion annually in diagnosis and treatment and ...

These pose a health risk to the public. Sahpra cautions the public to not purchase and/or consume such products as their ...

The SA Health Products Regulatory Authority has expressed concern at the increasing presence of counterfeit products such as ...

Diabetes and weight-loss drug tirzepatide (Mounjaro, Zepbound) was listed as a contributing factor in the death of a 58-year-old nurse from Scotland who died of multiple organ failure, septic shock, ...

Lifecore now operates at less than 35% utilization, meaning that it can almost triple revenue with virtually no additional ...

“Novo Nordisk does not promote, suggest, or encourage off-label use, or misuse, or any of our medications,” a spokesperson ...

The United States is the biggest trading partner for the European Union and Britain, whose economies could be at risk from ...

Amgen stock tumbled late Tuesday on a report that its high-profile weight-loss shot, MariTide, could be linked to bone ...

Lars Fruergaard Jørgensen began his career at Novo Nordisk as an economist in the health care, economy, and planning ...